BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camps C, Sirera R, Bremnes RM, Garde J, Safont MJ, Blasco A, Berrocal A, Sánchez JJ, Calabuig C, Martorell M. Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications. Lung Cancer 2006;52:343-7. [PMID: 16574270 DOI: 10.1016/j.lungcan.2006.02.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Terada T. Esophageal small cell carcinoma without neuroendocrine features but with KIT and PDGFRA expression: KIT as a useful marker of this type of tumor. J Gastrointest Cancer 2014;45 Suppl 1:132-5. [PMID: 24604264 DOI: 10.1007/s12029-014-9595-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Terada T. Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions. Pathol Oncol Res. 2012;18:1091-1093. [PMID: 21626441 DOI: 10.1007/s12253-011-9374-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
3 Spigel DR, Hainsworth JD, Simons L, Meng C, Burris HA, Yardley DA, Grapski R, Schreeder M, Mallidi PV, Greco FA. Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network. Journal of Thoracic Oncology 2007;2:854-61. [DOI: 10.1097/jto.0b013e31814617b7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
4 Fan H, Yuan Y, Wang J, Zhou F, Zhang M, Giercksky KE, Nesland JM, Suo Z. CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome. Histopathology 2013;62:1028-37. [PMID: 23570416 DOI: 10.1111/his.12111] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
5 Cameselle-teijeiro JM, Mato Mato JA, Fernández Calvo O, García Mata J. Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis—Prognostic and Predictive Factors. Mol Diagn Ther 2018;22:169-77. [DOI: 10.1007/s40291-018-0315-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol 2012; 18(13): 1545-1551 [PMID: 22509088 DOI: 10.3748/wjg.v18.i13.1545] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
7 Terada T. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Pathol Int 2009;59:247-50. [PMID: 19351368 DOI: 10.1111/j.1440-1827.2009.02358.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
8 Kurokawa Y, Matsuura N, Kawabata R, Nishikawa K, Ebisui C, Yokoyama Y, Shaker MN, Hamakawa T, Takahashi T, Takiguchi S, Mori M, Doki Y. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer. Ann Surg Oncol 2014;21 Suppl 4:S584-90. [PMID: 24743909 DOI: 10.1245/s10434-014-3690-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
9 Terada T. Primary small cell carcinoma of the mediastinum: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2009;26:247-50. [PMID: 18989797 DOI: 10.1007/s12032-008-9116-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
10 Roskoski R Jr. Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun 2007;356:323-8. [PMID: 17367763 DOI: 10.1016/j.bbrc.2007.02.156] [Cited by in Crossref: 262] [Cited by in F6Publishing: 248] [Article Influence: 17.5] [Reference Citation Analysis]
11 Stewart DJ. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol 2010;75:173-234. [PMID: 20047843 DOI: 10.1016/j.critrevonc.2009.11.006] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 10.5] [Reference Citation Analysis]
12 Shang L, Liu HJ, Hao JJ, Jiang YY, Shi F, Zhang Y, Cai Y, Xu X, Jia XM, Zhan QM. A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma. PLoS One. 2014;9:e111045. [PMID: 25337715 DOI: 10.1371/journal.pone.0111045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
13 Swarts DR, Ramaekers FC, Speel EJ. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta 2012;1826:255-71. [PMID: 22579738 DOI: 10.1016/j.bbcan.2012.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
14 Yokouchi H, Nishihara H, Harada T, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Goto A, Suzuki H, Dosaka-Akita H, Isobe H, Nishimura M, Munakata M. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker. Oncotarget 2017;8:39711-26. [PMID: 28055980 DOI: 10.18632/oncotarget.14410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Terada T. Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA. Prostate 2012;72:1150-6. [PMID: 22127977 DOI: 10.1002/pros.22464] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
16 Terada T. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes. Arch Gynecol Obstet 2010;282:413-6. [PMID: 20035340 DOI: 10.1007/s00404-009-1324-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
17 Terada T. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2010;27:1119-22. [PMID: 19859843 DOI: 10.1007/s12032-009-9345-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lebron MB, Brennan L, Damoci CB, Prewett MC, O'Mahony M, Duignan IJ, Credille KM, DeLigio JT, Starodubtseva M, Amatulli M, Zhang Y, Schwartz KD, Burtrum D, Balderes P, Persaud K, Surguladze D, Loizos N, Paz K, Kotanides H. A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth. Cancer Biol Ther 2014;15:1208-18. [PMID: 24921944 DOI: 10.4161/cbt.29523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]